Wide Ranks

BBLG

Bone Biologics Corp

1.26

Top Statistics
Market Cap 3 M Forward PE -0.6462 Revenue Growth 0.00 %
Current Ratio 11.22 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 2 M Total Cash Per Share 1.29 Total Debt
Total Debt To Equity Current Ratio 11.22 Book Value Per Share 5.44
All Measures
Short Ratio 18.00 % Message Board Id finmb_99330767 Shares Short Prior Month 352648
Return On Equity -1.19 City Burlington Uuid ef723e6d-c4c0-3645-8eff-e1206a869bb4
Previous Close 1.30 First Trade Date Epoch Utc 1 B Book Value 5.44
Beta 0.7360 Volume 50226 Price To Book 0.2316
Last Split Date 1 B Fifty Two Week Low 0.8000 Total Cash Per Share 1.29
Shares Short Previous Month Date 1 B Target Median Price 16.75 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 16.75 Net Income To Common -5119297
Short Percent Of Float 0.0349 Implied Shares Outstanding 2 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 143190 Average Volume10days 143190
Total Cash 2 M Next Fiscal Year End 1 B Held Percent Insiders 0.0521
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.30 Target Low Price 16.75 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.62 Open 1.25 Free Cashflow -4826930
State MA Dividend Yield 0.00 % Return On Assets -0.5725
Time Zone Short Name EST Trailing Eps -1.46 Day Low 1.22
Address1 2 Burlington Woods Drive Shares Outstanding 2 M Price Hint 4
Target High Price 16.75 Website https://www.bonebiologics.com 52 Week Change -0.6149
Average Volume 3 M Forward Eps -2.19 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 819.70 % Last Split Factor 1:8
Regular Market Day High 1.29 Is_sp_500 False Profit Margins 0.00 %
Fifty Two Week High 10.56 Day High 1.29 Shares Short 72057
Regular Market Open 1.25 Industry Key medical-devices Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0344 Operating Cashflow -6772514
Currency USD Time Zone Full Name America/New_York Market Cap 3 M
Is_nasdaq_100 False Zip 01803 Quote Type EQUITY
Industry Medical Devices Long Name Bone Biologics Corporation Regular Market Day Low 1.22
Held Percent Institutions 0.0459 Current Price 1.26 Address2 Suite 100
Financial Currency USD Current Ratio 11.22 Industry Disp Medical Devices
Number Of Analyst Opinions 1 Country United States Float Shares 1 M
Two Hundred Day Average 1.75 Enterprise Value -188369 Forward PE -0.6462
Regular Market Volume 50226 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration.

It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.

The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications.

Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.